Cancer Guide Blog: June 2008

Monday, June 30, 2008

Medical News Today News Alert

Dear Subscriber,

Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

----------------------------------------------
** BREAST CANCER News **

Massage For The Cure Day Only A Month Away
http://www.medicalnewstoday.com/articles/113311.php
On Monday, July 28, all 18 Greater Atlanta-area Massage Envy clinics will provide free 1-hour therapeutic massage sessions to any man or woman to benefit the Susan G. Komen for the Cure Greater Atlanta Affiliate.

Efforts Seek To Raise Breast Cancer Awareness Among Black Women, Encourage Minority Students To Seek Health Care Careers, Reduce Racial Health Dispari
http://www.medicalnewstoday.com/articles/113250.php
The following summarizes articles related to addressing racial and ethnic health disparities. <ul><li class="AdvisoryBullet">Clinton County, Ohio: <a href="http://www.cancerpreventioninstitute.

----------------------------------------------
** CANCER / ONCOLOGY News **

Orexo Report Abstral (Rapinyl) Approval In Europe
http://www.medicalnewstoday.com/articles/113324.php
Orexo AB (OMX: ORX), the Swedish pharmaceutical company, announces that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has issued a positive opinion recommending approval of Rapinyl, for breakthrough cancer pain.

Liver Phase I Results Presented At WCIO 2008 & Best Of ASCO(R)
http://www.medicalnewstoday.com/articles/113318.php
Celsion Corporation (NASDAQ: CLN) announced that the interim results from its second Phase I liver cancer confirmation study of ThermoDox in combination with Radio Frequency Ablation (RFA) treating patients with primary and metastatic liver cancer were presented at both Oral and Poster presentation at the WCIO 2008 and Best of ASCO® conference.

The Natural History Of Bladder Carcinoma In Situ After Initial Response To Bacillus Calmete-GÃºerin Immunotherapy
http://www.medicalnewstoday.com/articles/113269.php
ORLANDO, FL (UroToday.com) - The authors explored patterns of recurrence, muscle invasion, and disease specific mortality in patients with bladder carcinoma in situ (CIS) who responded to an induction course with intravesical BCG immunotherapy.

One Million New Skin Cancer Cases Expected In USA This Year
http://www.medicalnewstoday.com/articles/113268.php
According to the American Academy of Dermatology (AAD), there will be approximately one million new cases of skin cancer diagnosed in the United States in 2008. The AAD says that about one in every five Americans will develop skin cancer some time during his/her lifetime.

The Future Of Urologic Oncology: Peril And Promise
http://www.medicalnewstoday.com/articles/113266.php
ORLANDO, FL (UroToday.com) - Dr. Paul Lange presented the Ramon Guiteras lecture. Surgeon-scientists have made great contributions to medicine. However, we might be one generation from ignorance and two from obsolescence, he said.

Leukocyte InFusion Therapy Begins Clinical Trial Following Cancer 'Cure' In Mice
http://www.medicalnewstoday.com/articles/113261.php

Scientists at Wake Forest University Baptist Medical Center are about to embark on a human trial to test whether a new cancer treatment will be as effective at eradicating cancer in humans as it has proven to be in mice.

Caphosol Favorably Impacts Both The Rate And Severity Of Oral Mucositis In Cancer Patients
http://www.medicalnewstoday.com/articles/113204.php
New data show that use of CAPHOSOL® (<a href="http://www.caphosol.com/" target="_blank" rel="nofollow">http://www.caphosol.com/), an advanced oral electrolyte solution, resulted in both favorable impact on rates and severity of oral mucositis (OM) in cancer patients undergoing chemotherapy and radiation therapy.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

No news for this category today.

----------------------------------------------
** COLORECTAL CANCER News **

Bowel Cancer Patients Live Longer Taking Xeloda - Analysis Confirms That Oral Xeloda Is Superior To IV 5-FU
http://www.medicalnewstoday.com/articles/113289.php
A pre-planned multivariate analysis of the five-year follow-up data shows that patients receiving chemotherapy after-surgery to treat colon cancer, are more likely to live longer when taking the chemotherapy pill Xeloda (capecitabine), compared to those receiving 5-FU/FA intravenous (IV) chemotherapy.

New Data Show Preemptive Treatment May Significantly Reduce Skin Toxicities In Patients Receiving Vectibix(R) (Panitumumab)
http://www.medicalnewstoday.com/articles/113285.php
Amgen (NASDAQ: AMGN) announced updated results from the "STEPP" (Skin Toxicity Evaluation Protocol with Panitumumab) trial, the first prospective study to examine differences between preemptive and reactive skin treatment for skin toxicities in metastatic colorectal cancer (mCRC) patients receiving epidermal growth factor receptor (EGFr) therapy.

----------------------------------------------
** LUNG CANCER News **

No news for this category today.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

Chemotherapy Resistance Overcome In The Lab Using Re-Purposed Malaysian Folk Medication
http://www.medicalnewstoday.com/articles/113203.php
Researchers from McGill University's Faculty of Medicine have discovered a compound that reduces resistance to chemotherapy agents used to treat cancer. Their results were published in the June issue of The Journal of Clinical Investigation (JCI).

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

The Ratio Of Serum Testosterone To Prostate Specific Antigen Predicts Prostate Cancer In Hypogonadal Men
http://www.medicalnewstoday.com/articles/113270.php
ORLANDO, FL (UroToday.com) - Dr. Abraham Morgentaler and colleagues examined the relationship between testosterone (T) levels and PSA in hypogonadal men. 184 patients with symptomatic hypogonadism (T <300 ng/dL) and PSA of â‰¤4.

The Influence Of Statin Medications On PSA Velocity In Healthy Men
http://www.medicalnewstoday.com/articles/113267.php
ORLANDO, FL (UroToday.com) - Data is emerging about use of statins and risk reduction in development of prostate cancer (CaP). How do statins affect PSA? The authors previously observed that PSA levels decreased upon initiation of statin medications.

Teaching And Mentoring: A Multi-Center Laparoscopic Radical Prostatectomy Experience
http://www.medicalnewstoday.com/articles/113263.php
ORLANDO, FL (UroToday.com) - Canadian investigators created a teaching and mentoring method called "block" surgery to simplify and improve time efficiency and safety while maintaining acceptable oncological and functional outcomes during the learning curve of a laparoscopic radical prostatectomy (LRP).

Behavior, Social Factors Should Be Considered In Addressing Black Men's Prostate Cancer Screening Rates, Study Finds
http://www.medicalnewstoday.com/articles/113251.php
 "<a href="http://www.nmanet.org/images/uploads/Publications/OC724.pdf" target="_new">Personal Factors Affecting African-American Men's Prostate Cancer Screening Behavior</a>" (.pdf), <cite>Journal of the National Medical Association</cite>: The study seeks to identify the personal factors that affect black men's decisions to undergo prostate cancer screenings.

-------------------------------------------------------------

You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

Sunday, June 29, 2008

Medical News Today News Alert

Dear Subscriber,

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

----------------------------------------------
** BREAST CANCER News **

No news for this category today.

----------------------------------------------
** CANCER / ONCOLOGY News **

State Of The Art Lecture: What Are The Most Important Ongoing Clinical Trials In Urologic Oncology Worldwide?
http://www.medicalnewstoday.com/articles/113220.php
ORLANDO, FL (UroToday.com) - Dr. E. David Crawford presented information on challenges facing clinical trials from SWOG, ECOG and CALGB. Patient accrual for clinical trials is only 2-3%. Innumerable layers of rules and regulations have been created with numerous layers that increase costs and delays.

ThermoDox In Combination With Radio Frequency Ablation Liver Phase I Results Presented At WCIO 2008 & Best Of ASCO
http://www.medicalnewstoday.com/articles/113219.php
Celsion Corporation (NASDAQ: CLN) announced today that the interim results from its second Phase I liver cancer confirmation study of ThermoDox in combination with Radio Frequency Ablation (RFA) treating patients with primary and metastatic liver cancer were presented at both Oral and Poster presentation at the WCIO 2008 and Best of ASCO® conference.

Cancer "Cure" In Mice To Be Tested In Humans
http://www.medicalnewstoday.com/articles/113212.php
Scientists at Wake Forest University Baptist Medical Center are about to embark on a human trial to test whether a new cancer treatment will be as effective at eradicating cancer in humans as it has proven to be in mice.

Routine Perioperative Chemotherapy Instillation With Initial Transurethral Resection: A Cross Examination Of Economic Benefits
http://www.medicalnewstoday.com/articles/113208.php
ORLANDO, FL (UroToday.com) - Indisputable level-one evidence has demonstrated decreased recurrence rates of low-grade (LG) bladder tumors when initial bladder tumor resection is followed by chemotherapeutic perioperative instillation (PI).

Abstral (Rapinyl) Receives Positive CHMP Opinion For Breakthrough Cancer Pain - Europe
http://www.medicalnewstoday.com/articles/113135.php
ProStrakan Group plc (LSE: PSK), the international specialty pharmaceutical company, announces that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has issued a positive opinion recommending approval of Abstral (formerly branded as Rapinyl), the fast-acting tablet for breakthrough cancer pain.

Promising Cancer Drug Target In Prostate Tumors Identified By Researchers
http://www.medicalnewstoday.com/articles/113104.php
Scientists at Dana-Farber Cancer Institute report they have blocked the development of prostate tumors in cancer-prone mice by knocking out a molecular unit they describe as a "powerhouse" that drives runaway cell growth.

Pregnancy May Help Protect Against Bladder Cancer
http://www.medicalnewstoday.com/articles/113090.php
Pregnancy seems to confer some protection against bladder cancer in mice, scientists have found.Female mice that had never become pregnant had approximately 15 times as much cancer in their bladders as their counterparts that had become pregnant, according to new findings by investigators at the University of Rochester Medical Center.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

No news for this category today.

----------------------------------------------
** COLORECTAL CANCER News **

No news for this category today.

----------------------------------------------
** LUNG CANCER News **

No news for this category today.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

No news for this category today.

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

Sonocystography Following Open Radical Retropubic Prostatectomy (ORRP)
http://www.medicalnewstoday.com/articles/113215.php
ORLANDO, FL (UroToday.com) - Dr. Herbert Lepor and colleagues report their experience with 51 patients who underwent sonocystography on the eighth day following open radical retropubic prostatectomy (ORRP).

Serum PSA, DRE, DNA Methylation, PCA3, And TMPRSS2:ERG In Expressed Prostatic Secretion As Non-Invasive Predictors Of Biopsy Outcome
http://www.medicalnewstoday.com/articles/113210.php
ORLANDO, FL (UroToday.com) - New biomarkers for prostate cancer are taking stage alongside PSA. Clark and colleagues assessed utility of several biomarkers detected in expressed prostatic secretions (EPS) to predict prostate cancer biopsy yield.

The Efficacy Of Cytate As A Fluorescence Marker To Detect Prostate Cancer
http://www.medicalnewstoday.com/articles/113103.php
Researchers at the Institute for Ultrafast Spectroscopy and Lasers (IUSL) at The City College of New York (CCNY) have conducted time-resolved fluorescence measurement and optical imaging studies that demonstrate the efficacy of Cytate as a fluorescence marker to detect prostate cancer.

-------------------------------------------------------------

Saturday, June 28, 2008

Medical News Today News Alert

Dear Subscriber,

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

----------------------------------------------
** BREAST CANCER News **

No news for this category today.

----------------------------------------------
** CANCER / ONCOLOGY News **

Taming, Then Aiming, Viruses At Brain Tumors - "Engineered" Viruses May Hold Promise For Cancer Treatment
http://www.medicalnewstoday.com/articles/113189.php
It may sound like the plot of a medical drama, but this approach to fightingcancer is real. Scientists say they may someday be able to battle brain cancer, while using avirus to do it. Early results from the lab are promising.

Sorafenib, First Pharmaceutical Drug To Improve Survival Amongst Patients With Advanced Hepatocarcinoma
http://www.medicalnewstoday.com/articles/113177.php
International research involving the University Hospital of the University of Navarra, together with other hospitals in Spain, has shown that Sorafenib, an orally administered pharmaceutical medicine, results in patients with primary hepatocarcinomas (liver tumours) to live 40% more on average compared to those not taking the drug.

Second Phase 1 Oncology Trial Further Demonstrates Interleukin-7 Potential To Induce Dramatic And Prolonged CD4 And CD8 T Cell Expansion
http://www.medicalnewstoday.com/articles/113152.php
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced the publication of data from a phase 1 dose escalation study evaluating the effects of IL-7 therapy on human lymphocytes in subjects with non-hematologic, non-lymphoid cancer refractory to standard therapy.

Prognostic Value Of Re-TURB Of High Risk Non Invasive Bladder Cancer
http://www.medicalnewstoday.com/articles/113147.php
ORLANDO, FL (UroToday.com) - The authors evaluated the usefulness of second TURB and whether pathological outcomes of ReTUR have a prognostic impact on recurrence and progression of primitive T1G3 bladder cancer.

Phase 1 Study Of Multi-Dose Administration Of Intravesical CG0070 In Patients With Non-Muscle Invasive Bladder Cancer (NMIBC)
http://www.medicalnewstoday.com/articles/113140.php
ORLANDO, FL (UroToday.com) - CG0070 is a replication-competent adenovirus modified to replicate preferentially in retinoblastoma pathway-defective cancers and to express granulocyte-macrophage colony-stimulating factor (GM-CSF).

Thallion Receives Health Canada Approval To Initiate Phase II Study For TLN-232 In Metastatic Melanoma Patients
http://www.medicalnewstoday.com/articles/113121.php

Thallion Pharmaceuticals Inc. (TSX:TLN) announced it has received authorization from the Therapeutic Products Directorate of Health Canada to initiate a Phase II clinical trial evaluating TLN-232 as a treatment for metastatic melanoma in patients that have failed at least one prior therapy.

Avalon Pharmaceuticals Names Lead Development Candidate In Beta-Catenin Inhibitor Program
http://www.medicalnewstoday.com/articles/113112.php
Avalon Pharmaceuticals, Inc. (Nasdaq: AVRX), has announced the nomination of AVN316 as a lead clinical development candidate in its Beta-catenin Pathway Inhibitor program. This novel compound inhibits the Beta-catenin pathway and is a potent inducer of cancer cell death.

Recipients Of 2008 Awards, Grants Announced By ASTRO
http://www.medicalnewstoday.com/articles/112914.php
The American Society for Therapeutic Radiology and Oncology's Research Evaluation Committee has announced the recipients of several awards and grants that are funded by the Radiation Oncology Institute (formerly the ASTRO Education and Development Fund) and distributed each year as part of the organization's overall effort to prevent, treat and cure malignancies.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

No news for this category today.

----------------------------------------------
** COLORECTAL CANCER News **

Poverty, Poor Health Might Influence Colorectal Cancer Screening Attendance
http://www.medicalnewstoday.com/articles/113174.php
Patients who believe in the value of colorectal cancer screenings and fear cancer often say they would undergo preventive testing, but their intentions do not necessarily translate into action, according to a new study.

Metastatic Colon Cancer Research Benefits From $1.8M Award
http://www.medicalnewstoday.com/articles/113113.php
Through the generous philanthropic support of the Littlefield 2000 Trust, the American Association for Cancer Research (AACR) is pleased to announce three recipients of the 2008 Jeannik M. Littlefield-AACR Grants for Metastatic Colon Cancer Research, totaling $1.

----------------------------------------------
** LUNG CANCER News **

No news for this category today.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

No news for this category today.

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

ABC News NIGHTLINE Features HIFU With Sonablate(R) 500 As Non Invasive Treatment Option For Prostate Cancer
http://www.medicalnewstoday.com/articles/113164.php
USHIFU, LLC, the exclusive distributor of the minimally invasive Sonablate(R) 500 for prostate cancer treatment in North and South America, announced that the June 16, 2008 edition of ABC News NIGHTLINE featured a segment on high intensity focused ultrasound (HIFU) for treating prostate cancer outside of the United States using the Sonablate(R) 500.

Risk And Predictors Of Prostate Cancer In Men With Negative Repeat Saturation Biopsy
http://www.medicalnewstoday.com/articles/113157.php
ORLANDO, FL (UroToday.com) - These investigators sought to determine both the risk of future prostate cancer in patients that undergo negative repeat saturation biopsies and the criteria that should be used in decision making whether to do follow-up biopsy in a patient with a previous negative repeat saturation or not.

Prostate Cancer Screening Must Be Continued To Be Effective
http://www.medicalnewstoday.com/articles/113155.php
ORLANDO, FL (UroToday.com) - The AUA and American Cancer Society advocate offering men annual screening with serum PSA and DRE starting at age 50 years in the general population and earlier in high-risk men.

Prostate Cancer Characteristics Of Potential Candidates For Active Surveillance After Initial And Repeat Biopsy
http://www.medicalnewstoday.com/articles/113154.php
ORLANDO, FL (UroToday.com) - Active surveillance (AS) is a treatment option in patients diagnosed with low risk prostate cancer. Several recommendations for identification of low risk cancers are published and a repeat biopsy during AS plays a key role in such schemes.

Prostate Cancer: NICE Clarification Boosts NHS Treatment Options
http://www.medicalnewstoday.com/articles/113149.php
Physician experts at the British Association of Urological Surgeons' (BAUS) annual meeting this week heard how discussions with NICE have opened the way for patients with prostate cancer to have continued access to cryotherapy - a promising therapy threatened by earlier NICE guidance published in February.

Penile Rehabilitation In The Radical Prostatectomy Patient
http://www.medicalnewstoday.com/articles/113139.php
ORLANDO, FL (UroToday.com) - Dr. Ira Sharlip moderated a debate on penile rehabilitation. A consequence of radical prostatectomy (RP) is ED and its prevalence is reported between 9-93%. How penile rehabilitation is given and whether it works is debated.

-------------------------------------------------------------

Friday, June 27, 2008

Medical News Today News Alert

Dear Subscriber,

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

----------------------------------------------
** BREAST CANCER News **

Breakthrough Breast Cancer's Comment On Genetic Tests For Breast Cancer
http://www.medicalnewstoday.com/articles/113018.php
Dr Sarah Cant, Policy Manager at Breakthrough Breast Cancer, says: "This review looks at whether breast screening might be improved in the future by targeting women at higher than average genetic risk of breast cancer.

Genetic Profiling For Breast Cancer On The Horizon
http://www.medicalnewstoday.com/articles/112895.php
Cancer Research UK scientists have shown that it may soon be possible to offer women a genetic test to assess their risk of breast cancer which could aid early diagnosis for those at high risk of the disease.

----------------------------------------------
** CANCER / ONCOLOGY News **

Trained Dogs Able To Detect Ovarian Cancer's Specific Scent
http://www.medicalnewstoday.com/articles/113085.php
Ground-breaking research in the June issue of Integrative Cancer Therapies published by SAGE explored whether ovarian cancer has a scent different from other cancers and whether working dogs could be taught to distinguish it in its different stages.

UNISON Wins Compensation For Asbestos Victim Family
http://www.medicalnewstoday.com/articles/113069.php
The family of a former UNISON member has received more than Â£140,000 in compensation following his death from mesothelioma - a lung disease caused by exposure to asbestos in the workplace. Jim Crowe, from Wood Green in London, died aged 79, in June 2007 after developing the deadly disease.

Avastin(R) Shows Unprecedented Benefits In Colorectal Cancer Patients, Irrespective Of K-Ras Gene Mutation
http://www.medicalnewstoday.com/articles/113046.php
Data presented at the 10th World Congress on Gastrointestinal Cancer (WCGC) in Barcelona confirm that Avastin (bevacizumab) significantly improves survival in patients with metastatic colorectal cancer regardless of whether they have mutation in a gene known as K-Ras.

Einstein's Monoclonal Antibody Shows Encouraging Results In Clinical Trial Of Novel Melanoma Treatment
http://www.medicalnewstoday.com/articles/113037.php
Pain Therapeutics, Inc. recently announced the successful completion of its first clinical study utilizing a novel melanoma treatment, which the company licensed from Albert Einstein College of Medicine of Yeshiva University.

EMEA Recommends A New Warning For Epoetins For Their Use In Cancerpatients, Europe
http://www.medicalnewstoday.com/articles/113003.php
The European Medicines Agency (EMEA) has recommended updating the product information for epoetin-containing medicines with a new warning for their use in cancer patients stating that blood transfusion should be the preferred method of correcting anaemia in patients suffering cancer.

IMC-A12 Plus Temsirolimus Clinical Trial For Advanced Cancer Opens For Patient Enrollment
http://www.medicalnewstoday.com/articles/112955.php
ImClone Systems Incorporated (NASDAQ: IMCL), a global leader in the development and commercialization of novel antibodies to treat cancer, today announced that a Phase 1 clinical trial of IMC-A12, ImClone's fully human, IgG1 anti-insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody, plus the mTOR inhibitor temsirolimus in patients with advanced solid malignancies and lymphoma has opened for patient enrollment.

BSD-2000 Cancer Treatment System By BSD Medical Installed In Prestigious Liaocheng Peoples Hospital In China
http://www.medicalnewstoday.com/articles/112953.php
BSD Medical Corp. (NASDAQ:BSDM) announced that another BSD-2000 hyperthermia system has been purchased, installed and is now in use in China, at the Liaocheng Peoples Hospital located in Liaocheng City, in the Western Shandong Province of the People's Republic of China.

Mathematical Modeling May Help Leukemia Therapy
http://www.medicalnewstoday.com/articles/112932.php
A study published in the open-access journal PLoS ComputationalBiology demonstrates how sophisticated mathematical modelinghas encouraged the development of an optimally-timed vaccine forchronic myelogenousleukemia (CML).

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

Global Vaccine Alliance Board Approves $3.5B Investment Strategy That Includes HPV Vaccine
http://www.medicalnewstoday.com/articles/113026.php
 The board of the <A href="http://www.gavialliance.org/" target=_new>Global Alliance for Vaccines and Immunisation</A> (GAVI) -- a public-private partnership that invests in childhood vaccinations in developing countries -- endorsed a $3.

FDA Delays Approval Of Mercks HPV Vaccine Gardasil For Older Women
http://www.medicalnewstoday.com/articles/113021.php
 FDA has delayed a decision on <A href="http://www.merck.com/" target=_new>Merck</A>'s application to expand marketing of its human papillomavirus vaccine Gardasil to women ages 27 to 45, the company said Wednesday, the <A href="http://www.

----------------------------------------------
** COLORECTAL CANCER News **

Avastin(R) Shows Unprecedented Benefits In Colorectal Cancer Patients, Irrespective Of K-Ras Gene Mutation
http://www.medicalnewstoday.com/articles/112936.php
Data presented at the 10th World Congress on Gastrointestinal Cancer (WCGC) in Barcelona confirm that Avastin (bevacizumab) significantly improves survival in patients with metastatic colorectal cancer regardless of whether they have mutation in a gene known as K-Ras.

----------------------------------------------
** LUNG CANCER News **

Faulty DNA Repair May Increase Lung Cancer Risk In Nonsmokers
http://www.medicalnewstoday.com/articles/112991.php
People who have never smoked but whose cells cannot efficiently repair environmental insults to DNA are at higher risk of developing lung cancer than those with effective genomic repair capability, according to researchers from the Department of Epidemiology at The University of Texas M.

New Clinical Trial For Patients With Asbestos-Associated Lung Cancer
http://www.medicalnewstoday.com/articles/112933.php
The Mesothelioma Center within the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian Hospital and Columbia University Medical Center is now recruiting patients for a clinical research study of a new targeted radiation and chemotherapy protocol for pleural mesothelioma, a cancer of the lung's lining that is almost always caused by previous exposure to asbestos.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

FDA Files Application To Convert ONTAK(R) (Denileukin Diftitox) To Full Approval For Use In Cutaneous T-Cell Lymphoma (CTCL)
http://www.medicalnewstoday.com/articles/112959.php
Eisai Corporation of North America announced that the U.S. Food and Drug Administration (FDA) has accepted for priority review a supplemental biologics license application (sBLA) for ONTAK(R).

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

Elevated Biomarkers Predict Risk For Prostate Cancer Recurrence
http://www.medicalnewstoday.com/articles/112992.php
A simple blood test screening for a panel of biomarkers can accurately predict whether a patient who has had prostate cancer surgery will have a recurrence or spread of the disease.Calling their findings a major step forward in prostate cancer care, Texas researchers report in the June 15 issue of Clinical Cancer Research, a journal of the American Association for Cancer Research, that the presence of seven of these biomarkers can predict prostate cancer risk with 86.

Patients With Prior TURP Undergoing Robotic Assisted Laparoscopic Radical Prostatectomy Have Higher Positive Surgical Margin Rates
http://www.medicalnewstoday.com/articles/112984.php
ORLANDO, FL (UroToday.com) - With the incidence of robotic-assisted radical prostatectomy (RALP) increasing, questions regarding the significance of margin status have arisen. Patients with a history of a prior transurethral resection of the prostate (TURP), may have a higher incidence of positive margins because of the prior surgery.

Possible Link Between Gene Variants (SNPs) And Prostate Cancer Risk
http://www.medicalnewstoday.com/articles/112982.php
ORLANDO, FL (UroToday.com) - Dr. Jianfeng Xu, Wake Forest University discussed SNPs and CaP risk. CaP risk variants are now linked to the risk of developing CaP. CaP is the strongest hereditary cancer, at 42%.

Increasing Incidence Of No Residual And Low Volume Prostate Cancer: A Study Of 1792 Radical Prostatectomies
http://www.medicalnewstoday.com/articles/112979.php
ORLANDO, FL (UroToday.com) - No cancer in the specimen?! How often does this happen following radical prostatectomy? Zynger and colleagues examined a cohort of 1792 men who underwent RRP from 1/2003 to 12/2006.

Ejaculatory Duct Epithelium On Prostate Biopsies Predicts Deterioration Of Semen Parameters After Biopsy
http://www.medicalnewstoday.com/articles/112975.php
ORLANDO, FL (UroToday.com) - These authors previously reported that transrectal ultrasound guided biopsy of the prostate may have a negative impact on semen parameters. Possible mechanisms for the observed semen changes include: 1.

Robotic Prostatectomy: A Review Of Outcomes Compared With Laparoscopic And Open Approaches
http://www.medicalnewstoday.com/articles/112972.php
UroToday.com - In the online version of Urology, The group of Dr. Ashutosh Tewari at Cornell University review outcomes comparisons of open (RRP), laparoscopic (LRP), and robotic assisted (RALP).

Current Applications For Prostate-Specific Antigen Doubling Time
http://www.medicalnewstoday.com/articles/112971.php
UroToday.com - In the online version of European Urology, Dr. Michelle Ramirez and colleagues from UC Davis discuss present applications of PSA doubling time (PSADT). Where PSADT is most applicable in managing patients with prostate cancer is emphasized.

Anxiety And Depression In Patients With Prostate Cancer And Other Urogenital Cancer: A Longitudinal Study
http://www.medicalnewstoday.com/articles/112970.php
UroToday.com - In the online version or Urologic Oncology, Dr. Andreas Hinz and associates from Germany report on a longitudinal study to assess psychological distress in cancer patients. They sought to investigate the impact of the cancer, side effects related to treatment of the cancer and patient anxiety regarding possible cancer recurrence.

Active Surveillance For The Management Of Prostate Cancer In A Contemporary Cohort
http://www.medicalnewstoday.com/articles/112968.php
UroToday.com - In the online version of Cancer, Dr. Marc Dall'Era and colleagues at UCSF report on their experience with active surveillance (AS) for prostate cancer (CaP). Active surveillance was offered to men with Gleason score <6, PSA <10ng/ml, no Gleason grade 4 or 5 cancer, less than 33% of biopsy cores involved, and clinical T1/T2a tumors.

-------------------------------------------------------------

Thursday, June 26, 2008

Medical News Today News Alert

Dear Subscriber,

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

----------------------------------------------
** BREAST CANCER News **

Wall Street Journal Examines Use Of MRIs, Ultrasound In Detecting Breast Cancer
http://www.medicalnewstoday.com/articles/112819.php
 Although annual mammograms for many years have been the "simple prescription" for women concerned about breast cancer, physicians are now increasingly recommending that women at higher risk for the disease receive other tests, such as an MRI or ultrasound, which are potentially more sensitive forms of screening, the <CITE>Wall Street Journal</CITE> reports.

CuraGen Announces Initiation Of Phase II Trial Of CR011-vcMMAE In Patients With Advanced Breast Cancer
http://www.medicalnewstoday.com/articles/112768.php
CuraGen Corporation (Nasdaq: CRGN), a clinical-stage biopharmaceutical company focused on oncology, announced today the treatment of the first patient in its CR011-vcMMAE Phase II breast cancer study.

----------------------------------------------
** CANCER / ONCOLOGY News **

Personalized Therapy For Brain Tumors Advanced By Major Grant
http://www.medicalnewstoday.com/articles/112859.php
Researchers at The University of Texas M. D. Anderson Cancer Center will advance two new therapeutic approaches for malignant brain tumors and develop biomarkers to guide treatment decisions under a major translational research grant from the National Cancer Institute.

Immutep Reports That LAG-3 Enhances Activity Of A Cellular Cancer Immunotherapy In Preclinical Studies
http://www.medicalnewstoday.com/articles/112858.php
Immutep S.A., a biopharmaceutical company specialized in immunostimulatory and immunomodulatory treatments of cancer and infectious or autoimmune disease, announced today the publication of research conducted by Cell Genesys, Inc.

Comparative Analysis Shows Chemotherapy Pill Xeloda Should Become Standard Of Care In Colon, Colorectal And Stomach Cancers
http://www.medicalnewstoday.com/articles/112809.php
Results from a meta-analysis involving data from six phase III studies show that patients taking the chemotherapy pill Xeloda actually live longer than those receiving intravenous (IV) chemotherapy 5-FU/FA*.

Does Hydronephrosis On Preoperative Axial CT Imaging Predict Worse Outcomes For Nephrouretectomy Patients For Upper-Tract Urothelial Carcinoma?
http://www.medicalnewstoday.com/articles/112799.php
ORLANDO, FL (UroToday.com) - Dr. Casey Ng and colleagues evaluated whether hydronephrosis in the setting of upper tract TCC was a marker for more aggressive disease and worse outcomes. 106 patients from two institutions were included in the study.

Bladder Cancer In Spinal Cord Injury Patients
http://www.medicalnewstoday.com/articles/112793.php
ORLANDO, FL (UroToday.com) - Finally, University of California at Irvine investigators retrospectively evaluated 32/1319 (2.4%) SCI patients who developed bladder cancer that was detected a mean of 34 years (range 16-62) following SCI.

Phase II Study To Evaluate Efficacy/Tolerability Of Intravesical Vicinium In Patients With Carcinoma In SITU Treated With Bacille Calmette-GuÃ©rin
http://www.medicalnewstoday.com/articles/112788.php
ORLANDO, FL (UroToday.com) - Vicinium™ is a fusion protein comprised of a humanized scFv, specific for EpCAM (epithelial cell adhesion molecule), and a truncated fragment of Pseudomonas exotoxin A.

Vermillion Files 510(k) Application With U.S. Food & Drug Administration For OVA1 Ovarian Tumor Triage Test
http://www.medicalnewstoday.com/articles/112765.php
Vermillion, Inc. (Nasdaq: VRML), a molecular diagnostics company, announced that it has submitted a 510(k) pre-market notification application to the U.S. Food & Drug Administration (FDA) requesting regulatory clearance of its Ovarian Tumor Triage Test known as OVA1(TM).

Female Survivors Take Action Against A Cancer Deadlier Than Cervical Cancer By Launching The American Bladder Cancer Society
http://www.medicalnewstoday.com/articles/112758.php
Bladder cancer survivors and caregivers will be celebrating the 4th of July with a renewed spirit and new purpose this year. They have banded together to raise awareness of this forgotten cancer, and will officially launch the American Bladder Cancer Society (ABLCS).

Female Survivors Take Action Against A Cancer Deadlier Than Cervical Cancer By Launching The American Bladder Cancer Society
http://www.medicalnewstoday.com/articles/112757.php
Bladder cancer survivors and caregivers will be celebrating the 4th of July with a renewed spirit and new purpose this year. They have banded together to raise awareness of this forgotten cancer, and will officially launch the American Bladder Cancer Society (ABLCS).

NICE Drug Reviews Terminated When Manufacturers Fail To Submit Evidence
http://www.medicalnewstoday.com/articles/112737.php
Because insufficient evidence was provided by the manufacturers, NICE is unable to recommend the use the following treatments in the NHS: - bevacizumab in combination with paclitaxel for the first-line treatment of metastatic breast cancer - bevacizumab in addition to platinum-based chemotherapy for the first-line treatment of patients with inoperable advanced, metastatic or recurrent non-small-cell lung cancer (other than predominantly squamous cell histology) - carmustine implants as an adjunct to surgery in patients with recurrent glioblastoma multiforme (a type of brain cancer) for whom surgery is appropriate - cetuximab for the treatment of colorectal cancer following failure of oxaliplatin-containing chemotherapy Andrew Dillon, NICE Chief Executive said: "NICE is committed to producing timely guidance to the NHS using our fast-track single technology appraisal process.

Cancer And Tobacco Are Growing Health Concerns In Africa
http://www.medicalnewstoday.com/articles/112729.php
In an unprecedented meeting between the media, cancer and tobacco control nongovernmental organizations, and the health care sector, African journalists gathered in Johannesburg, South Africa yesterday to discuss Africa's growing cancer and tobacco crisis.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

No news for this category today.

----------------------------------------------
** COLORECTAL CANCER News **

Clinical Trials For Colon Cancer Screening Technology
http://www.medicalnewstoday.com/articles/112894.php
A Northwestern University biomedical engineer who has developed optical technology shown to be effective for the early detection of colon cancer has received a $7.5 million grant over five years from the National Cancer Institute to further study an instrument that potentially could become a routine colon cancer screening test and to launch large-scale clinical trials.

Leading Colorectal Patient Organisation Calls On EU Countries To Improve Poor Standards Of Care
http://www.medicalnewstoday.com/articles/112746.php
europacolon has called on all governments to implement existing EU recommendations on colorectal cancer screening following a new report published that shows the disease to be significantly neglected despite being the second most common cancer in Europe.

First Comprehensive Report On Colorectal Cancer (CRC) Care In Europe And Australia Reveals Urgent Need For Action
http://www.medicalnewstoday.com/articles/112744.php
The first cross-country report on the management and funding of colorectal cancer (CRC) reveals an urgent need for action to improve the survival of patients diagnosed with this common cancer in Europe and Australia.

----------------------------------------------
** LUNG CANCER News **

No news for this category today.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

Clavis Pharma Receives Us Orphan Drug Designation For Elacyt(TM) For The Treatment Of Acute Myeloid Leukaemia
http://www.medicalnewstoday.com/articles/112742.php
Clavis Pharma announced that the US Food & Drug Administration (FDA) has granted orphan drug designation to ELACYT(TM) for the treatment of Acute Myeloid Leukaemia (AML). Within haematology, Clavis Pharma is currently conducting a Phase II study with ELACYT in patients undergoing second salvage therapy for AML, and a Phase I study with ELACYT in combination with idarubicin, in patients undergoing first salvage treatment (patients with refractory /relapsed AML).

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

Does The Training Level Of The First Assistant Have An Impact On Blood Loss In Radical Prostatectomies?
http://www.medicalnewstoday.com/articles/112800.php
ORLANDO, FL (UroToday.com) - Blood loss in radical prostatectomies has been an issue for a long time. New operative techniques led to an optimization regarding not only nerve sparing but also blood sparing attempts.

Does BMI Impact PSA Concentration By Variation In Plasma Volume?
http://www.medicalnewstoday.com/articles/112798.php
ORLANDO, FL (UroToday.com) - Recent reports suggest that men with higher BMI have lower PSA concentrations due to dilution of a set PSA amount by a larger plasma volume. The study published in JAMA in November of 2007, drew such conclusion from a cohort of men that had a known diagnosis of prostate cancer (and went on to prostatectomy).

Multiplicative Model Of Prostate Cancer Susceptibility Alleles On 8q24 AND 17q: Which Combination Is Associated With Aggressive Cancer?
http://www.medicalnewstoday.com/articles/112786.php
ORLANDO, FL (UroToday.com) - A collection of 5 single-nucleotide polymorphisms (SNPs) at 8q24 (3 total), 17q12, and 17q24 has received much attention. A publication in NEJM in January of 2008 demonstrated that this combination of SNPs together with family history had a significant relationship with development of prostate cancer.

Prostate Cancer Deaths Double In Men With BRCA2
http://www.medicalnewstoday.com/articles/112725.php
Men with <a href="http://info.cancerresearchuk.org/cancerandresearch/cancers/prostate/" target="_blank" rel="nofollow">prostate cancer </a> caused by a faulty <a href="http://info.cancerresearchuk.

-------------------------------------------------------------

Subscription Confirmation

Dear Subscriber,

Thank you for subscribing to newsletters from MyBreastCancerNetwork.com. You will receive your first newsletter tonight. Please note that some email providers block certain emails, so you may need to look in your bulk or spam folder and mark the newsletter as "not spam."

You have subscribed to the following newsletter:

Breast Cancer

Here’s what you can look forward to receiving each week:

The Weekly Checkup - Every Tuesday!

The most important news to keep you informed
Stories, advice, and support from our top doctors and experts
Videos on the latest research, developments, and treatments
Tools and tips to help manage your health
Weekly polls - what our community members think about topics in the news

The SharePost Roundup - Every Thursday! We pick the very best SharePosts written by our community members and experts. Get recommendations, questions and answers, and read about the experiences of people just like you.

If you are receiving this in error and do not wish to receive any of these newsletters, please click here and you will be promptly removed.

You may also change your subscriptions now, or change them later on by clicking the link at the bottom of any newsletter.

We hope you enjoy your newsletters!

The MyBreastCancerNetwork.com Team

If you have questions or comments about this newsletter or about our newsletter service in general, please contact us at comments@thcn.com.

Read our privacy policy

The HealthCentral Network
1655 N. Fort Myer Drive, #400
Arlington, VA 22209
(c) 2008 The HealthCentral Network, Inc. All rights reserved.

Click to confirm your News Alert subscription

Medical News Today received a request to start sending daily Medical News Alerts to the e-mail address cancerhelpguide@gmail.com

-------------------------------------------------------------------------------

To verify your subscription to news alerts, please click the link below:
http://www.medicalnewstoday.com/newsalerts.php?confirm=y&cc=1a5d8a81d16a27a4aff5d55acc8d5e67

To cancel the subscription, please click the link below:
http://www.medicalnewstoday.com/newsalerts.php?confirm=n&cc=1a5d8a81d16a27a4aff5d55acc8d5e67

To amend your subscription details, please click the link below:
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y

For AOL users, please copy and paste the relevant link into a browser window.

If you have any questions, please reply to this e-mail

Thanks

The Medical News Today Team
http://www.medicalnewstoday.com

-------------------------------------------------------------------------------

How to Avert Colon Cancer

Unhygienic cologne makes a huge impact on human body. There are lots of supplementary diseases attached with it. People can also get attract to colon cancer which can be deadly if proper precautions are not carried out or performed.

Colon cancer can be prevented if it is detected in its early stages. There are many medical treatments available for prevention of colon cancer for e.g. sigmoidoscopy and many others which are highly costly and every one cannot afford such medical expenses. Except medical treatment people can also practice many other things which can help to lower the hazard of colon cancer. Some of the things which people can follow are as follows:

Smoking is injurious to health and the ill-effects of smoking on human body are known by every one. Smoking plays a very important role in causing lung cancer. But in many cases excessive smoking can lead to colon cancer. If smoking is quited forever there are favorable chances of averting colon cancer.

People should keep a habit of working out daily or exercise daily as it would help them to clean out the accumulated waste in the colon and will help the person feel fit and energized.

People are used to eat junk foods everyday. This can have a bad impact on health of any person. Hence people should avoid junk foods and start eating vegetable and fruits everyday.

Obesity can also be very harmful. People should adopt methods which can be helpful to reduce their weight.

In short a fit body can help people to fight any diseases.

What is Vaginal Cancer?

Vaginal cancer is not a common cancer. Vaginal cancer is cancer that begins in the vagina. There are two basic types of vaginal cancer:

* Squamous cell carcinoma is cancer that forms in squamous cells. Squamous cell vaginal cancer spreads slowly and usually stays near the vagina without spreading, but it is possible for it to spread to the lungs and liver. This is the most common type of vaginal cancer. Squamous cell carcinoma is usually found in women that are 60 years old or older.

* Adenocarcinoma is cancer that begins in glandular cells. Adenocarcinoma is much more likely than squamous cell cancer to spread to the lungs and lymph nodes. Adenocarcinoma is usually diagnosed in women who are 30 years old or younger.

The most serious and significant risk factor for developing either type of vaginal cancer is exposure to the drug DES (Diethylstilbestrol). DES is a synthetic hormone that was given to pregnant women between 1940 and 1971. It was believed that DES would prevent miscarriages. It is possible (maybe probable) that DES will increase the risk of uterine, ovarian, or breast cancer in women who took it, and DES has also has been linked to an increased risk of clear cell carcinoma of the vagina or cervix in daughters exposed to DES before birth.

We also know that exposure to the human papilloma virus (HPV) or having an HPV infection is a real risk factor for developing vaginal cancer. The FDA (Food and Drug Administration) recently approved the use of the vaccine, Gardisil, for girls and women between the ages of 9 and 26. This vaccine is administered in the form of three shots given over a six-month period. Gardisil has proven very effective and perfectly safe.

Milos Pesic is a respected surgeon who specializes in treating all forms of cancer and runs a comprehensive Cancer Treatment web site. For more articles and resources on cancer symptoms and treatments, breast cancer, skin cancer, lung cancer, prostate and colon cancer and much more, visit his site at:

=> http://cancer.need-to-know.net/

Article Source: http://EzineArticles.com/?expert=Milos_Pesic

Leukemia For Twins and Stem Cells Solutions

Although there are no accurate data for concordance rates of leukemia in infant twins, anecdotally it seems to be exceptionally high, perhaps approaching one hundred percent that is, if one twin has it, unfortunately so will the other. If correct, this suggests that MLL gene fusion in utero has a dramatic impact, ensuring subsequent leukemia. But for children aged two to six years with acute lymphoblastic leukemia, the concordance rate is considerably lower at around five percent. This still represents a one hundred fold extra risk of leukemia for the twin of a patient with acute lymphoblastic leukemia but also indicates the need for some additional postnatal event for which there is a one in twenty chance, or ninety five percent discordance. This suggests, at a minimum, a "two hit" model for the natural course of childhood leukemia.
Colorado eye surgery,Manhattan plastic surgery,Plastic surgery fort worth,Pennsylvania cosmetic surgery,Orange County breast implants

If this model of leukemia development is correct, then, for every child with acute lymphoblastic leukemia diagnosed, there should be at least twenty healthy children who have had a chromosome translocation, a functional leukemia fusion gene, and a covert preleukaemic clone generated in utero. This possibility has been investigated by screening unselected samples of newborn cord blood for fusion genes. About six hundred samples have been screened, and around one percent have a leukemia TELAML1 fusion gene. This one percent represents a hundred times the cumulative rate or risk of acute lymphoblastic leukemia, indicating that the frequency of conversion of the preleukaemic clone to overt disease is low. The real bottleneck in development of acute lymphoblastic leukemia therefore seems to be a stringent requirement for a second "hit" after birth-that is, exposure and additional chromosomal or molecular abnormality.

A key issue to resolve is what exposures or events might precipitate the chromosome breaks whose improper repair initiates or promotes childhood leukemia. Given the biological diversity of leukemia, it is highly unlikely that there is a single cause. Even for a defined biological subtype of the disease, there probably is not one cause as such but a causal mechanism. As with other cancers, this is likely to involve an interaction of exposure, exogenous or endogenous, with inherent genetic susceptibility, and chance. Epidemiological evidence suggests that ionizing radiation; certain chemicals such as benzene, viruses, and bacteria may play a part in the development of some subtypes of leukemia and lymphoma in adults and children.
Whether any of these exposures have a major role in childhood leukemia is uncertain, but large scale case control molecular epidemiological studies in Britain and the United States may provide answers. The United Kingdom children's cancer study (UKCCS) seeks to address several hypotheses on different exposures, combined with definition of biological subtypes of disease and genetic studies. It and a parallel US study have already ruled out electromagnetic fields as a major factor in leukemia aetiology.

Having stem cells extracted from the cord blood at birth and stored in a cord blood bank or a stem cells bank is a way to protect your child from future diseases.
Hyperglycaemic attack symptoms,Treatment early stage diabetes,Bare minerals makeup,71 weight loss tips,Weight loss success stories

It can be very useful as it contains hematopoietic stem cells, progenitor cells. The stem cells in the cord blood are mainly used to treat blood and immune system related genetic diseases, cancers and blood disorders like diabetes or leukemia.
Cancer awareness bracelet,Skin cancer charts graphs,FDA Cancer Cures,Breast cancer symptoms,Makeup tips for teenagers

Wayne Channon, Director of Cells4Life Ltd, a Stem cell and cord blood storage expert.
Hula Hoop Exercises,Neolight hair laser comb,Stop smoking laser,Quit smoking laser,Stop smoking programs,

Stem cell and cord blood storage

Article Source: http://EzineArticles.com/?expert=Wayne_Channon

Can Natural Herbal Remedies Help Cancer Victims?

It is always difficult to promote the use of natural methods to treat this disease. Cancer is a very serious disease, which kills millions of people throughout the world and particularly in the West. Traditional medicine wants to arrogate to itself the exclusive right of scrutiny and treatment in this area. Yet the results are far from satisfying.

The cancer continues to defy the technology of modern medicine and remains, after decades of intensive research, an enigmatic disease, responsible each year of millions of death. While a few types of cancer are now successfully treated, several others remain extremely difficult to fight and are a major cause of mortality. More than ever, finding new ways in which we can improve the effectiveness of current anti-cancer therapies is of paramount importance. The naturotherapy is one of those means.

Many oncologists recognize naturaltherapy as a preventive mode in order to avoid the development of cancer. They also recommend regular consumption of certain foods as a method to support conventional treatments for those who are undergoing cancer treatment, radiation and chemotherapy. However, for some, herbal remedies or natural cancer treatments have no positive effects on cancers, either preventive or curative.

A global study on a large scale has shown that if each person consumed at least 150g of a variety of fresh fruits and vegetables per day, the risk of cancer would be decreased by 30%. If there were a pill that would fall by 30% the risk of cancer, it is likely that everyone would consume it. Why not try natural remedies? In fact, most plants used in natural remedies can grow in your own backyard (Astragalus, Burdock root, Green tea, for example). Along with natural cancer alternative and/or conventional cancer treatment, alimentation plays an important role in your recovery from cancer.

A good alimentation has not only a significant role in cancer prevention, but can also provide the cancer patient who must undergo chemotherapy or radiotherapy, the means to fight against the aggressor. No treatment can work properly without a healthy diet, either conventional or natural cancer treatment.

The remedies exist in the form of dried or fresh plants for preparation and capsules or liquid ready to use. Of course, it is illegal in the USA to claim that a natural remedy can treat cancer, but we believe it is unfair not to mention these methods, which are supported by some doctors and testimonials patients, have no anticancer properties.

Many supplements and natural remedies can be used to fight against cancer, either alone or in supplement to conventional therapies. Our Cancer herbal remedies may reduce hair loss, improve appetite, reduce nausea (for those undergoing chemotherapy), and amplify the positive tumor shrinking effects of radiation therapy. To learn more, visit our cancer herbal remedies website and save 5%.

Raphaelo is a nutritionist who strongly believes in natural healing and disease prevention. He loves to share his own personal beneficial experience with natural remedies to others. To learn more about natural cancer remedies, nails vitamins, etc. Visit his cancer herbal remedies website.

Article Source: http://EzineArticles.com/?expert=Raphaelo_Steff

How Can Your Prevent and Treat Your Oral Cancer?

In oral cancer, the cancer cells or tissues present within oral cavity of the mouth. Oral cancer includes the parts such as cheek, lip, gum, salivary gland and floor of the mouth. This type of cancer will affect only the people more than 45 years, but it can get developed at any stage. Most of the oral cancer includes the throat, tongue and floor of the mouth. Throat cancer includes the part behind your mouth. A person who is affected by oral cancer may have great health risks if he is a male or above 40 years old.

The American research center says that nearly 30,000 people are affected by oral and throat cancer in United States per year. According to the recent estimation from America about 7,000 people die because of throat and oral cancer. Oral cancer may originate from any part of the mouth as a primary lesion and may be varied in types. They look very smaller in microscope and are malignant. They can spread easily to the other parts. If the oral cancer is detected in the earlier stage it is successfully curable, but it is very difficult to identify because in the early stage it does not have any pain but only toothache.

Symptoms for Oral Cancer

Following are the some of the common symptoms of the oral cancer:

You can experience bleeding in gums and red or white patches on the gums. A lump found on the lips, floor of the mouth, at the side of the cheeks. Feeling difficult to chew or swallow. Having Continuous toothache and loosing teeth. Bad breath and difficult to open the jaws. A lump on your neck. A sore present in your mouth or tongue which does not heal quickly.

Factors for Oral Cancer

Tobacco is the major factor responsible for oral and throat cancer. A person who drinks alcohol will be affected by oral cancer mostly than the non-drinking persons. Smoking cigarettes, pipes, chewing tobacco leaves, using snuff powder will lead to oral cancer. The person who has regular head ache may also be affected. Family background is also another reason. High exposure of ultraviolet rays on the lips is also one of the factors. Among 3 any 1 person will be affected by oral cancer due to UV rays.

Preventions

Stop smoking and have a regular dentist checkup twice a year. Avoid chewing gums and tobacco leaves. Use sun screen balms on your lips and sunscreen lotions on your body to protect yourself from UV rays. Do self-examination for your tongue, teeth and throat. Have a rich nutritious food.

Treatments for Oral Cancer

Surgery, radiation and chemotherapy are the major treatments for removing tumor cells or tissues. Surgery depends on the size and location of the tumor and it can be removed easily without any damage. Radiation therapy uses x-rays to kill the tumor cells and it can be used during surgery for destroying small tumors. In chemotherapy the drugs are used to kill the cancer cells. You can stimulate drugs either through veins or orally. The type of drug depends on the size and location of the tumor. If the tumor cell is larger it can be treated with the combination of chemotherapy and radiation therapy.

Further information can be found throughout the web, such as Fruity Health Directory which has a great resource for cancer information.

Article Source: http://EzineArticles.com/?expert=Mike_Lovatt

What is Cancer?

Cancer is not a single disease with a single cause or cure. Cancer is the result when cells divide uncontrollably and invade other nearby tissue in the body. Cancer spreads through the body by way of blood circulation or by the clear fluid that travels through the lymphatic system and carries cells that help fight infections and other diseases.

There are more than 100 types of cancers, but they are divided into the following main categories:

1. Carcinoma: Carcinoma is cancer that begins on the skin or in tissues that line or cover the internal organs.

2. Sarcoma: Sarcoma is cancer that begins in bone, cartilage, fat, muscle, blood vessels, or other connective tissue.

3. Leukemia: Leukemia is cancer that starts in blood-forming tissue such as the bone marrow and causes large numbers of abnormal blood cells to be produced that then enter the bloodstream.

4. Lymphoma and myeloma: Lymphoma and myeloma are cancers that begin in the cells that make up the immune system.

The body is made up of many different types of cells. Cells grow and divide in a normal and controlled way to produce more cells as they are needed. When cells get old or are damaged, they die and then they are replaced with new cells.

When this normal process goes wrong (the genetic material - DNA - of a cell becomes damaged or changed) the body begins producing mutations that affect normal cell growth. The result is that cells don't die when they should, and new cells form when the body doesn't need them. These extra and mutated cells then can form a mass of tissue that is called a tumor.

All tumors are not cancerous. Most tumors are benign. "Benign" means that the tumor is not cancerous. Tumors that are cancerous are called "malignant" tumors.

=> http://cancer.need-to-know.net/

Article Source: http://EzineArticles.com/?expert=Milos_Pesic

Types of Thyroid Cancer

Thyroid is an organ which is present at the base of throat and produces number of hormones that help to control the heart rate, blood pressure, body temperature and weight of the body. It is a butterfly shaped gland and also known as Adam's apple. Even though it is a small organ it produces hormones to regulate the aspect of metabolism and used to burn the calories quickly. Sometimes small solids or fluid-filled lumps called as nodules may develop in your thyroid. Most common type of thyroid cancer can be removed by the treatment of surgery.
Cosmetic implants,Boca Raton Cosmetic Dentist,Dentist in my area,Dentistry dentures,Cosmetic dentistry beverly hills

Most of the thyroid cancers are non-cancerous cancer. The thyroid cancer can be diagnosed by ultra sound or by surgical removal and subsequent histological examination. The thyroid cancer can be removed by surgical treatment. As the thyroid cancer take up iodine or radioactive iodine, it is commonly used to treat thyroid carcinoma.
Michigan dental implants,Los Angeles cosmetic dentist,Summer weight loss,Sacred heart diet,Candida diet and catabolism

There are two types of thyroid cancer they are benign and malignant cancer. Benign cancer is a non cancerous tumor. The cells of benign do not spread to the other part of the body and they are not usually a threat of life. More than 90 percent of them are affected by benign. The malignant are the tumor which contains the cancer cells. The cancer cells of malignant thyroid tumor will spread to the other part of body and affect them. They are more serious and sometimes that are life threatening. The cancer cells of malignant will break away and enter into the blood streams through lymph and thus the cancer spreads and forms a new tumor in other organs and it is called as metastasis.

Types of Thyroid Cancer

The other types of thyroid cancer are papillary cancer, Follicular cancer, medullary thyroid cancer and Ana plastic cancer.

Papillary Cancer

The papillary is the most common type of thyroid cancer. Out of 10 about 6 of them are diagnosed by thyroid cancer. It is the most common type of disease among women and it mostly affects the younger people and sometimes it may spread to the neck and lymph of the body. Mostly it tends to grow slowly and if it is detected in the earlier stage it can be treated.

Follicular Cancer

It is most often diagnosed in young and middle aged people. About 15 percent of thyroid cancers are this type. This type of cancer may spread to the other part such as bone and lymph.

Medullary Cancer

About 5 to 10 percent of thyroid cancer is medullary cancer. It can be treated easily if it has been found in earlier stage. It arises only from C cell and not from the follicular cell.

Ana Plastic Cancer

This type of cancer affect only one or two percent of people. It arises in the follicular cell and it is difficult to recognize.

Further information can be found throughout the web, such as Fruity Health Directory which has a great resource for cancer information.

Article Source: http://EzineArticles.com/?expert=Mike_Lovatt

Cancer Guide Blog

Monday, June 30, 2008

Medical News Today News Alert

Sunday, June 29, 2008

Medical News Today News Alert

Saturday, June 28, 2008

Medical News Today News Alert

Friday, June 27, 2008

Medical News Today News Alert

Thursday, June 26, 2008

Medical News Today News Alert

Subscription Confirmation

Click to confirm your News Alert subscription

How to Avert Colon Cancer

What is Vaginal Cancer?

Leukemia For Twins and Stem Cells Solutions

Can Natural Herbal Remedies Help Cancer Victims?

How Can Your Prevent and Treat Your Oral Cancer?

What is Cancer?

Types of Thyroid Cancer

Partner Sites

Blog Archive

Health Information

About Me